Filo

Filo is a synthetic biology company focused on developing a platform to program biology for therapeutic applications. The company leverages advanced genetic engineering and computational tools to design and build "living medicines," specifically engineered microbial strains that can sense and respond to disease states within the human body. By focusing on the gut microbiome and other systemic interfaces, Filo aims to create highly precise, localized treatments for complex conditions such as inflammatory bowel disease and metabolic disorders. Their approach combines high-throughput screening with modular biological circuits to accelerate the development of next-generation live biotherapeutics.